We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App





Siemens Highlights Presents Latest Breakthroughs in Healthcare

By LabMedica International staff writers
Posted on 03 Feb 2025

Siemens Healthineers (Forchheim, Germany) is presenting its transformative healthcare solutions at Medlab Middle East 2025 that are designed to empower professionals to provide the highest level of care to their patients. More...

Siemens is highlighting various products highlighted including its two new high-volume hematology analyzers, the Atellica HEMA 570 and 580. Designed to meet the hematology testing needs of today’s high-volume labs, both instruments share fast throughput and an identical footprint. Also featured at the event is the IMMULITE 2000 XPi immunoassay system that provides multiple tests on a single, easy-to-use analyzer. This makes it simple to adjust to changes in demand and scale capabilities without disrupting day-to-day operations. Additionally, Siemens is presenting the CN-3000 and CN-6000 coagulation designed to meet the small-sized, mid- and high-volume hemostasis testing solutions. The CN Systems leverage optical testing methodology with intelligent software to automate and standardize sample management for reliable results, reduced repeat testing, and reagent waste. Siemens is also highlighting Atellica Integrated Automation which consolidates revolutionary sample management technology, intelligent software, and IT to provide workflow efficiency with the flexibility to add decapping with little or no additional footprint.

Among its compact solutions featured at the event is the Atellica DCA Analyzer which puts fast, quality HbA1c and ACR results right at the fingertips. Experience the performance and precision you need to improve outcomes. Designed with the speed, standardization, and personalization required to boost efficiencies and meet growing demand, the Atellica DCA Analyzer can be placed wherever it is needed when space is at a premium. Also featured at the event is the RAPIDPoint 500e System that elevates Siemens’ blood gas offering to a new level. This end-to-end blood gas solution reduces the daily burden of device management and enables healthcare professionals to give full care and attention to their patients. Moreover, Siemens is also demonstrating the Atellica VTLi patient-side immunoassay analyzer for high-sensitivity troponin testing at the point of care. It produces accurate results in just 8 minutes, improving ED throughput, reducing stress and strain on acute care clinicians, and aiding in optimizing the use of time and resources of busy laboratories.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Hemoglobin Stool Test
CerTest FOB 50 + 200 One Step Combo Card Test
New
Toxoplasma Gondii Test
Toxo IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.